Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Sale
Class A Common Stock
2026-03-03$3.46/sh−170,000$588,200→ 6,259,863 total
Signature
/s/ Jonathan Golightly, attorney-in-fact|2026-03-04